Revised SPCs: Humira (adalimumab) products

Weight increase has been added as an adverse event. The mean change from baseline ranged from 0.3 kg to 1.0 kg across adult indications compared to -0.4 kg to 0.4 kg for placebo over 4-6 months. Weight increase of 5-6kg has also been observed in longer-term studies (no control).

Source:

electronic Medicines compendium